Breakthrough in kidney treatment offers hope to people with diabetes – Xinhua

SYDNEY, April 15 (Xinhua) – A revolutionary new treatment for kidney disease has shown immense hope for "hundreds of millions of people with diabetes around the world."

The results of the medical test undertaken by the George Institute for Global Health in Sydney on Monday showed that kidney failure was reduced by 33%, heart failure by 30% and major cardiovascular events of 20%.

Developed to reduce glucose levels, the drug, canagliflozin, was tested in a study involving more than 4,000 people in 34 countries.

According to the principal author of the findings of Professor Vlado Perkovic of the George Institute for Global Health, it is urgent to find a new treatment for kidney failure, with diabetes rates rising sharply worldwide.

"Diabetes is the leading cause of kidney failure in the world, but for nearly two decades, no new treatment has been available to protect kidney function," he said.

"The final results of this trial constitute a major medical advance as people with diabetes and kidney disease are at an extremely high risk of kidney failure, heart attack, stroke and stroke. death."

"We now have a very effective way to reduce this risk by using a pill once a day."

Meg Jardine, co-author, said that 5 million people worldwide would have kidney failure by 2035 and that hundreds of millions of others would have diabetes, "c & # Is a major breakthrough ".

"What we have shown is that this drug not only protects diabetics against kidney failure, but also against heart disease, heart failure and other cardiovascular complications" , she said.

"What is important, it is also to help people who already have reduced kidney function and who are at particularly high risk."